Condition: Advanced Cancer
Interventions: Drug: FLX475; Drug: Pembrolizumab
Sponsor: FLX Bio, Inc.
Recruiting
https://ift.tt/2xppUoD
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου